Search

everythinglearnresearchcommunity

for

Search:↓

Changes in certain RNA and protein levels may contribute to alopecia areata and could be treatment targets.

A woman developed alopecia after her second Pfizer vaccine but regrew her hair with treatment and had no issues after a booster shot.

A man with a birthmark on his scalp developed hair loss that improved with treatment, but the link between the birthmark and hair loss was unclear.

A 3-year-old girl with skin mast cell buildup and congenital baldness improved with treatment, suggesting a rare link between these conditions.

Farudodstat may help treat alopecia areata by protecting hair follicles.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

A woman's hair grew back after stopping acitretin for psoriasis and getting steroid treatment, and low vitamin D might be linked to alopecia severity.

Homeopathy helped regrow hair in a severe hair loss case.

Dextroamphetamine may help treat alopecia areata.

The three-layer microneedle system effectively delivers minoxidil into the skin, showing potential as a safe and efficient treatment for hair loss.

More severe alopecia areata is linked to more follicular stelae, but not to treatment response.

Researchers developed a method to measure active ingredients in a hair loss treatment cream.

The treatment is effective and safe for severe alopecia areata in children, but not for total or universal hair loss.

A man had an unusual type of hair loss that didn't match known patterns and didn't improve with treatment.

The Sinclair Shedding Scale is effective for diagnosing Alopecia Areata Incognita and monitoring treatment success.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

The document concludes that certain rats and mice are useful for studying hair loss in humans and testing treatments.

Alopecia areata is influenced by genetics and immune system factors, and better understanding could improve treatments.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

Alopecia areata is becoming more common in Japan, with a need for better treatments, especially for severe and pediatric cases.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

The combination of cyclosporine and PUVA might help treat severe alopecia areata.

The conclusion is that understanding and addressing the psychological effects of alopecia areata is important for effective treatment.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

Alopecia areata is complex, with genetic and immune factors, and animal models are key for future treatment research.

Scientists have found specific genes linked to different hair loss conditions, which could lead to new treatments.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Dupilumab may help treat alopecia areata in children with atopic dermatitis, but it can also cause new hair loss.